Copyright Reports & Markets. All rights reserved.

Global Enoxaparin Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Enoxaparin Sodium Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 20 mg/0.2mL
    • 1.3.3 30 mg/0.3mL
    • 1.3.4 40 mg/0.4mL
    • 1.3.5 60 mg/0.6mL
    • 1.3.6 80 mg/0.8mL
    • 1.3.7 100 mg/1mL
    • 1.3.8 120 mg/0.8mL
    • 1.3.9 150 mg/1mL
    • 1.3.10 300mg/3mL
  • 1.4 Market Analysis by Sales Channel
    • 1.4.1 Overview: Global Enoxaparin Sodium Consumption Value by Sales Channel: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital & Clinic
    • 1.4.3 Pharmacy
    • 1.4.4 Others
  • 1.5 Global Enoxaparin Sodium Market Size & Forecast
    • 1.5.1 Global Enoxaparin Sodium Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Enoxaparin Sodium Sales Quantity (2019-2030)
    • 1.5.3 Global Enoxaparin Sodium Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Enoxaparin Sodium Product and Services
    • 2.1.4 Sanofi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Techdow (Hepalink)
    • 2.2.1 Techdow (Hepalink) Details
    • 2.2.2 Techdow (Hepalink) Major Business
    • 2.2.3 Techdow (Hepalink) Enoxaparin Sodium Product and Services
    • 2.2.4 Techdow (Hepalink) Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Techdow (Hepalink) Recent Developments/Updates
  • 2.3 Teva
    • 2.3.1 Teva Details
    • 2.3.2 Teva Major Business
    • 2.3.3 Teva Enoxaparin Sodium Product and Services
    • 2.3.4 Teva Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Teva Recent Developments/Updates
  • 2.4 Nanjing King-friend
    • 2.4.1 Nanjing King-friend Details
    • 2.4.2 Nanjing King-friend Major Business
    • 2.4.3 Nanjing King-friend Enoxaparin Sodium Product and Services
    • 2.4.4 Nanjing King-friend Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Nanjing King-friend Recent Developments/Updates
  • 2.5 Rovi
    • 2.5.1 Rovi Details
    • 2.5.2 Rovi Major Business
    • 2.5.3 Rovi Enoxaparin Sodium Product and Services
    • 2.5.4 Rovi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Rovi Recent Developments/Updates
  • 2.6 Fresenius Kabi
    • 2.6.1 Fresenius Kabi Details
    • 2.6.2 Fresenius Kabi Major Business
    • 2.6.3 Fresenius Kabi Enoxaparin Sodium Product and Services
    • 2.6.4 Fresenius Kabi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Fresenius Kabi Recent Developments/Updates
  • 2.7 Fosun Pharma(Gland Pharma)
    • 2.7.1 Fosun Pharma(Gland Pharma) Details
    • 2.7.2 Fosun Pharma(Gland Pharma) Major Business
    • 2.7.3 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product and Services
    • 2.7.4 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Fosun Pharma(Gland Pharma) Recent Developments/Updates
  • 2.8 Amphastar
    • 2.8.1 Amphastar Details
    • 2.8.2 Amphastar Major Business
    • 2.8.3 Amphastar Enoxaparin Sodium Product and Services
    • 2.8.4 Amphastar Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Amphastar Recent Developments/Updates
  • 2.9 Sandoz (Novartis)
    • 2.9.1 Sandoz (Novartis) Details
    • 2.9.2 Sandoz (Novartis) Major Business
    • 2.9.3 Sandoz (Novartis) Enoxaparin Sodium Product and Services
    • 2.9.4 Sandoz (Novartis) Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Sandoz (Novartis) Recent Developments/Updates
  • 2.10 Apotex
    • 2.10.1 Apotex Details
    • 2.10.2 Apotex Major Business
    • 2.10.3 Apotex Enoxaparin Sodium Product and Services
    • 2.10.4 Apotex Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Apotex Recent Developments/Updates
  • 2.11 Huadong Medicine
    • 2.11.1 Huadong Medicine Details
    • 2.11.2 Huadong Medicine Major Business
    • 2.11.3 Huadong Medicine Enoxaparin Sodium Product and Services
    • 2.11.4 Huadong Medicine Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Huadong Medicine Recent Developments/Updates
  • 2.12 Cipla
    • 2.12.1 Cipla Details
    • 2.12.2 Cipla Major Business
    • 2.12.3 Cipla Enoxaparin Sodium Product and Services
    • 2.12.4 Cipla Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Cipla Recent Developments/Updates
  • 2.13 Taj Pharma
    • 2.13.1 Taj Pharma Details
    • 2.13.2 Taj Pharma Major Business
    • 2.13.3 Taj Pharma Enoxaparin Sodium Product and Services
    • 2.13.4 Taj Pharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Taj Pharma Recent Developments/Updates
  • 2.14 Chengdu Baiyu Pharmaceutical
    • 2.14.1 Chengdu Baiyu Pharmaceutical Details
    • 2.14.2 Chengdu Baiyu Pharmaceutical Major Business
    • 2.14.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.14.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
  • 2.15 Changzhou Qianhong Bio-pharma
    • 2.15.1 Changzhou Qianhong Bio-pharma Details
    • 2.15.2 Changzhou Qianhong Bio-pharma Major Business
    • 2.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product and Services
    • 2.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
  • 2.16 Beijing SL Pharmaceutical
    • 2.16.1 Beijing SL Pharmaceutical Details
    • 2.16.2 Beijing SL Pharmaceutical Major Business
    • 2.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Beijing SL Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Enoxaparin Sodium by Manufacturer

  • 3.1 Global Enoxaparin Sodium Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Enoxaparin Sodium Revenue by Manufacturer (2019-2024)
  • 3.3 Global Enoxaparin Sodium Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Enoxaparin Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Enoxaparin Sodium Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Enoxaparin Sodium Manufacturer Market Share in 2023
  • 3.5 Enoxaparin Sodium Market: Overall Company Footprint Analysis
    • 3.5.1 Enoxaparin Sodium Market: Region Footprint
    • 3.5.2 Enoxaparin Sodium Market: Company Product Type Footprint
    • 3.5.3 Enoxaparin Sodium Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Enoxaparin Sodium Market Size by Region
    • 4.1.1 Global Enoxaparin Sodium Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Enoxaparin Sodium Consumption Value by Region (2019-2030)
    • 4.1.3 Global Enoxaparin Sodium Average Price by Region (2019-2030)
  • 4.2 North America Enoxaparin Sodium Consumption Value (2019-2030)
  • 4.3 Europe Enoxaparin Sodium Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Enoxaparin Sodium Consumption Value (2019-2030)
  • 4.5 South America Enoxaparin Sodium Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Enoxaparin Sodium Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 5.2 Global Enoxaparin Sodium Consumption Value by Type (2019-2030)
  • 5.3 Global Enoxaparin Sodium Average Price by Type (2019-2030)

6 Market Segment by Sales Channel

  • 6.1 Global Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 6.2 Global Enoxaparin Sodium Consumption Value by Sales Channel (2019-2030)
  • 6.3 Global Enoxaparin Sodium Average Price by Sales Channel (2019-2030)

7 North America

  • 7.1 North America Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 7.2 North America Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 7.3 North America Enoxaparin Sodium Market Size by Country
    • 7.3.1 North America Enoxaparin Sodium Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Enoxaparin Sodium Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 8.2 Europe Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 8.3 Europe Enoxaparin Sodium Market Size by Country
    • 8.3.1 Europe Enoxaparin Sodium Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Enoxaparin Sodium Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 9.3 Asia-Pacific Enoxaparin Sodium Market Size by Region
    • 9.3.1 Asia-Pacific Enoxaparin Sodium Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Enoxaparin Sodium Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 10.2 South America Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 10.3 South America Enoxaparin Sodium Market Size by Country
    • 10.3.1 South America Enoxaparin Sodium Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Enoxaparin Sodium Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Enoxaparin Sodium Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Enoxaparin Sodium Sales Quantity by Sales Channel (2019-2030)
  • 11.3 Middle East & Africa Enoxaparin Sodium Market Size by Country
    • 11.3.1 Middle East & Africa Enoxaparin Sodium Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Enoxaparin Sodium Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Enoxaparin Sodium Market Drivers
  • 12.2 Enoxaparin Sodium Market Restraints
  • 12.3 Enoxaparin Sodium Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Enoxaparin Sodium and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Enoxaparin Sodium
  • 13.3 Enoxaparin Sodium Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Enoxaparin Sodium Typical Distributors
  • 14.3 Enoxaparin Sodium Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
    According to our (Global Info Research) latest study, the global Enoxaparin Sodium market size was valued at US$ 3411 million in 2023 and is forecast to a readjusted size of USD 5520 million by 2030 with a CAGR of 7.0% during review period.
    The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
    Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
    In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.
    This report is a detailed and comprehensive analysis for global Enoxaparin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Enoxaparin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Enoxaparin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Enoxaparin Sodium market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Enoxaparin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Enoxaparin Sodium
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Enoxaparin Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Enoxaparin Sodium market is split by Type and by Sales Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    20 mg/0.2mL
    30 mg/0.3mL
    40 mg/0.4mL
    60 mg/0.6mL
    80 mg/0.8mL
    100 mg/1mL
    120 mg/0.8mL
    150 mg/1mL
    300mg/3mL
    Market segment by Sales Channel
    Hospital & Clinic
    Pharmacy
    Others
    Major players covered
    Sanofi
    Techdow (Hepalink)
    Teva
    Nanjing King-friend
    Rovi
    Fresenius Kabi
    Fosun Pharma(Gland Pharma)
    Amphastar
    Sandoz (Novartis)
    Apotex
    Huadong Medicine
    Cipla
    Taj Pharma
    Chengdu Baiyu Pharmaceutical
    Changzhou Qianhong Bio-pharma
    Beijing SL Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Enoxaparin Sodium product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Enoxaparin Sodium, with price, sales quantity, revenue, and global market share of Enoxaparin Sodium from 2019 to 2024.
    Chapter 3, the Enoxaparin Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Enoxaparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Sales Channel, with sales market share and growth rate by Type, by Sales Channel, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Enoxaparin Sodium market forecast, by regions, by Type, and by Sales Channel, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Enoxaparin Sodium.
    Chapter 14 and 15, to describe Enoxaparin Sodium sales channel, distributors, customers, research findings and conclusion.

    Buy now